XIST and colorectal cancer: In response to miR-93-5p, XIST adjusts the expression of HIF-1A and promotes the EMT process, proliferation and migration and tumorigenesis of colorectal cancer, suggesting that XIST may serve as a diagnostic and therapeutically relevant marker (34).